Center for Medicine in the Public Interest

The Center for Medicine in the Public Interest (CMPI) is a non-profit medical issues research group.[1] It was founded by the Pacific Research Institute.[2] CMPI's research agenda deals with clinical outcomes and econometric studies that analyze the value of new medicines and genomic and molecular-based medical innovation.

CMPI is a 501(c)3 organization and as such is not permitted to devote a substantial part of its activity to lobbying. Its officers have written articles on various issues including price controls on pharmaceutical products in publicly funded healthcare schemes in the United States,[3] and restrictions on advertising in the European Union.[4] The Economist Intelligence Unit has written that the organisation generally takes a pro-drug industry viewpoint.[5]

Personnel

CMPI was founded by Peter Pitts, former FDA Associate Commissioner for External Relations under the Bush administration, and Dr. Robert Goldberg, former fellow at the Manhattan Institute.[6]

CMPI Senior Fellows include:

Funding

Funders include PhRMA and Pfizer.[7]

Reports

CMPI has published studies on the value of new cancer drugs, the cost-effectiveness of certain Alzheimer's treatments, evidence-based medicine, drug counterfeiting[8] and healthcare terrorism.

References

  1. ↑ Herper, Matthew (2007-07-25). "The Nissen Doctrine". Forbes. Retrieved 2008-01-14.
  2. ↑ Lee Fang (Nov 18, 2009). "Exclusive: Attacks On Health Reform Orchestrated By Yet Another Shadowy Corporate Front Group — ‘CMPI’". Center for American Progress. Retrieved 19 November 2009.
  3. ↑ Goldberg, Robert (2006-12-25). "HillaryCare Comes Back". The Weekly Standard (News America Incorporated). Retrieved 2008-01-14.
  4. ↑ Pitts, Peter J. (2006-04-12). "Power to the Patients". Wall Street Journal. Retrieved 2008-01-14.
  5. ↑ "USA healthcare: FDA centenary prompts politicking". Economist Intelligence Unit (Economist Group). 2006-07-05. Retrieved 2008-01-14.
  6. ↑ Jason Lee Miller (2008-08-01). "Are Google Results Hazardous To Your Health?". WebProNews. iEntry, Inc. Retrieved 2008-01-14.
  7. ↑ http://www.politico.com/news/stories/0708/11570.html
  8. ↑ Laurie Sullivan (2006-06-13). "Pharmaceuticals Slowly Adopting RFID To Protect Prescription Drug Supplies". Information Week. CMP Media LLC. Retrieved 2008-01-14.

External links

This article is issued from Wikipedia - version of the Monday, March 07, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.